Ferumoxytol
- Generic Name
- Ferumoxytol
- Brand Names
- Feraheme
- Drug Type
- Small Molecule
- Chemical Formula
- Fe3O4
- CAS Number
- 722492-56-0
- Unique Ingredient Identifier
- G6N3J05W84
- Background
Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) .
...
- Indication
This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron or have experienced an unsatisfactory response to oral iron or
who have chronic kidney disease (CKD) .
- Associated Conditions
- Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 50
- Registration Number
- NCT06483061
- Locations
- 🇨🇦
Peter S. Allen MRI Unit, Edmonton, Alberta, Canada
Calculating Wall Shear Stress in Infant Pulmonary Veins
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 20
- Registration Number
- NCT06440408
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
- Conditions
- Interventions
- First Posted Date
- 2023-04-13
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Christopher J Chermansky, MD
- Target Recruit Count
- 30
- Registration Number
- NCT05811377
- Locations
- 🇺🇸
UPMC Magee Women's Hospital, Pittsburgh, Pennsylvania, United States
Predicting Stroke Risk in ICAD With Novel MRI
- First Posted Date
- 2022-08-25
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 100
- Registration Number
- NCT05515874
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Early Antenatal Support for Iron Deficiency Anemia
- Conditions
- Interventions
- First Posted Date
- 2020-02-20
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 80
- Registration Number
- NCT04278651
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- Conditions
- Interventions
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Auerbach Hematology Oncology Associates P C
- Target Recruit Count
- 104
- Registration Number
- NCT04268849
- Locations
- 🇺🇸
Auerbach Hematology and Oncology, Baltimore, Maryland, United States
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
- Conditions
- Interventions
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 76
- Registration Number
- NCT04205266
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
- First Posted Date
- 2019-03-28
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- AMAG Pharmaceuticals, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT03893045
- Locations
- 🇺🇸
Biomedical Research LLC, Miami, Florida, United States
🇺🇸Gwinnett Research Institute, Buford, Georgia, United States
🇵🇱Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wrocław, Poland
Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient
- Conditions
- Interventions
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT03777514
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
- Conditions
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 124
- Registration Number
- NCT03657433
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.